The central dogma of drug delivery is to steer therapeutic cargos to target tissues and/or cells to achieve maximal therapeutic efficacy with minimal toxic effects.Application of biomimetic designs as promising sustained drug release and site-targeted delivery systems for a variety of therapeutic agents from different fields of cancer therapy has gained a remarkable degree of interest in recent years.